Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioavailability assessment from pharmacologic data: method and clinical evaluation

G Stagni1, A M Shepherd, Y Liu

  • 1College of Pharmacy, University of Texas at Austin 78712, USA.

Journal of Pharmacokinetics and Biopharmaceutics
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-to-Event Analysis of Polatuzumab Vedotin-Induced Peripheral Neuropathy to Assist in the Comparison of Clinical Dosing Regimens.

CPT: pharmacometrics & systems pharmacology·2017
Same author

Nosocomial post-traumatic Rhizomucor soft tissue and bone infection treated with liposomial amphotericin B: case report.

Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology·2016
Same author

Fingolimod Hydrochloride Gel for Dermatological Applications: Optimization of Formulation Strength and Effect of Colloidal Oatmeal (Aveeno®) as Penetration Enhancer.

AAPS PharmSciTech·2016
Same author

How much do we know about schizophrenia and how well do we know it? Evidence from the Schizophrenia Library.

Psychological medicine·2014
Same author

Childhood adversity in schizophrenia: a systematic meta-analysis.

Psychological medicine·2012
Same author

Perineural infusion of 0.5% ropivacaine for successful treatment of phantom limb syndrome: a case report.

Minerva anestesiologica·2009
Same journal

Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Effect of plasma protein and tissue binding on the time course of drug concentration in plasma.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Pharmacokinetics of methotrexate in solid tumors.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.

Journal of pharmacokinetics and biopharmaceutics·2010
See all related articles

A new method uses pharmacologic data to assess drug bioavailability. This approach models the relationship between drug effect and input rate, enabling accurate estimation of drug absorption and systemic availability.

Area of Science:

  • Pharmacology
  • Pharmacokinetics
  • Biopharmaceutics

Background:

  • Assessing drug bioavailability is crucial for understanding drug efficacy and safety.
  • Existing methods may have limitations in accurately determining drug input and absorption rates.
  • Pharmacologic data offers a potential source for novel bioavailability assessment techniques.

Purpose of the Study:

  • To introduce and validate a novel method for assessing drug bioavailability using pharmacologic data.
  • To develop a generalized model relating observed effect (E) to drug input rate (f).
  • To estimate unknown drug input rates (f) from pharmacologic data using deconvolution.

Main Methods:

  • A generalized model E = phi (ce delta * f) was developed, where ce delta is the effect site impulse response and phi is the transduction function.

Related Experiment Videos

  • Cubic splines were used to express phi and ce delta for versatility.
  • Simultaneous analysis of data from two i.v. infusion doses estimated model parameters.
  • An implicit deconvolution method estimated the unknown input rate (f) from test treatment data.

    • Main Results:

    • Simulations demonstrated accuracy and precision, even with high measurement error.
    • Large intrasubject variability in model functions could lead to biased absorption estimates.
    • Application to a verapamil study in healthy volunteers yielded reasonably accurate estimates of input rate and systemic availability (F).
    • A slight underestimation trend was observed (93.6% +/- 14 vs. true 100% F).

    Conclusions:

    • The novel method provides a versatile approach to assess drug bioavailability from pharmacologic data.
    • The model accurately estimates drug input rates and systemic availability, though variability needs consideration.
    • This method holds promise for improving pharmacokinetic assessments in clinical settings.